These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36298496)

  • 1. Planning and Organization of the COVID-19 Vaccination Campaign: An Overview of Eight European Countries.
    Cadeddu C; Rosano A; Villani L; Coiante GB; Minicucci I; Pascucci D; de Waure C
    Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of the COVID-19 vaccination campaigns in France, Israel, Italy and Spain and their impact on health and economic outcomes.
    Antonini M; Eid MA; Falkenbach M; Rosenbluth ST; Prieto PA; Brammli-Greenberg S; McMeekin P; Paolucci F
    Health Policy Technol; 2022 Jun; 11(2):100594. PubMed ID: 34976711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Cannes 1993 to the present.
    Van Damme P; Verwimp G
    Vaccine; 1998 Nov; 16 Suppl():S3-6. PubMed ID: 9915024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of COVID-19 and Vaccination Coverage in the Italian Population as of October 2021.
    Altobelli E; Marzi F; Angelone AM; Mazzocca R; Mastrodomenico M; Petrocelli R; Marziliano C
    Int J Environ Res Public Health; 2022 Jan; 19(1):. PubMed ID: 35010756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study.
    Chen Z; Zheng W; Wu Q; Chen X; Peng C; Tian Y; Sun R; Dong J; Wang M; Zhou X; Zhao Z; Zhong G; Yan X; Liu N; Hao F; Zhao S; Zhuang T; Yang J; Azman AS; Yu H
    BMC Med; 2022 Apr; 20(1):130. PubMed ID: 35369871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns.
    Ho LL; Gurung S; Mirza I; Nicolas HD; Steulet C; Burman AL; Danovaro-Holliday MC; Sodha SV; Kretsinger K
    Int J Infect Dis; 2022 Jun; 119():201-209. PubMed ID: 35398300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccination in the Americas: Progress and challenges after the 2009 A(H1N1) influenza pandemic.
    Ropero-Álvarez AM; El Omeiri N; Kurtis HJ; Danovaro-Holliday MC; Ruiz-Matus C
    Hum Vaccin Immunother; 2016 Aug; 12(8):2206-2214. PubMed ID: 27196006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015.
    Jorgensen P; Mereckiene J; Cotter S; Johansen K; Tsolova S; Brown C
    Vaccine; 2018 Jan; 36(4):442-452. PubMed ID: 29287683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Registry Systems for COVID-19 Vaccines and Rate of Acceptability for Vaccination Before and After Availability of Vaccines in 12 Countries: A Narrative Review.
    Papagiannis D; Malli F; Gourgoulianis KI
    Infect Dis Rep; 2022 Feb; 14(1):121-133. PubMed ID: 35200443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
    Subaiya S; Tabu C; N'ganga J; Awes AA; Sergon K; Cosmas L; Styczynski A; Thuo S; Lebo E; Kaiser R; Perry R; Ademba P; Kretsinger K; Onuekwusi I; Gary H; Scobie HM
    PLoS One; 2018; 13(7):e0199786. PubMed ID: 29965975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micro-planning in a wide age range measles rubella (MR) campaign using mobile phone app, a case of Kenya, 2016.
    Ismail A; Tabu C; Onuekwusi I; Otieno SK; Ademba P; Kamau P; Koki B; Ngatia A; Wainaina A; Davis R
    Pan Afr Med J; 2017; 27(Suppl 3):16. PubMed ID: 29296151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects of COVID-19 Vaccination in Romania: Challenges and Potential Solutions.
    Dascalu S; Geambasu O; Covaciu O; Chereches RM; Diaconu G; Dumitra GG; Gheorghita V; Popovici ED
    Front Public Health; 2021; 9():644538. PubMed ID: 33643998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do Tuscan people adhere to meningococcal C vaccination during an emergency campaign?
    Bechini A; Paolini D; Pieralli F; Baggiani L; Mereu G; Santini MG; Brocca T; Gostinicchi S; Gori E; Boccalini S; Bonanni P; Bonaccorsi G
    J Prev Med Hyg; 2018 Sep; 59(3):E187-E193. PubMed ID: 30397674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk mapping associated with organization of a COVID-19 immunization campaign].
    Le Tohic S; Basso S; Peillard L
    Ann Pharm Fr; 2022 Sep; 80(5):697-710. PubMed ID: 35085572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Vaccination Centers in a National Mass Immunization Campaign-Policymaker Insights from the German COVID-19 Pandemic Vaccine Roll-Out.
    Danek S; Achelrod D; Wichmann O; Schwendicke F
    Vaccines (Basel); 2023 Sep; 11(10):. PubMed ID: 37896955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The new National Immunization Program 2017-2019 and the Essential Care Levels: what is going to change?].
    De Waure C; Sisti LG; Poscia A; Ricciardi W
    Ig Sanita Pubbl; 2017; 73(5):405-418. PubMed ID: 29433128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-country evidence on the role of national governance in boosting COVID-19 vaccination.
    Aida T; Shoji M
    BMC Public Health; 2022 Mar; 22(1):576. PubMed ID: 35321676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and changes: immunization program managers share perspectives in a 2012 national survey about the US immunization system since the H1N1 pandemic response.
    Seib K; Chamberlain A; Wells K; Curran E; Whitney EA; Orenstein WA; Hinman AR; Omer SB
    Hum Vaccin Immunother; 2014; 10(10):2915-21. PubMed ID: 25483633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covid-19 vaccine management (Comirnaty and mrna-1273 Moderna) in a teaching hospital in Italy: a short report on the vaccination campaign.
    Papini F; Grassi N; Guglielmi G; Gattini V; Rago L; Bisordi C; Scateni M; Totaro M; Tulipani A; Porretta A; Tavoschi L; Guercini J; Luchini G; Briani S; Privitera GP; Baggiani A
    Environ Health Prev Med; 2021 Sep; 26(1):99. PubMed ID: 34592930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.